Norwegian version of this page

Pancreatic pathology

About the group

Mechanisms that underlie treatment resistance, such as tumour heterogeneity, tumour-stroma interactions, and metabolic rewiring are investigated on human tumour tissues and in primary human cell cultures.

The research group is part of the Norwegian Cancer Society´s National Group of Expertise on Pancreatic Cancer.

Projects

• Morphological (intra-)tumour heterogeneity and its correlation with structural and functional diversity in pancreatic cancer.
  Funded by The Norwegian Cancer Society.
• Characterisation of residual cancer following neoadjuvant therapy for pancreatic cancer.
  Funded by Helse Sør-Øst.
• Ex vivo culturing of precision-cut human pancreatic cancer slices.
• Metabolic rewiring and chemoresistance in pancreatic cancer.
  Funded by Helse Sør-Øst, Family Blix Endowment, and Fondsstiftelsen at Oslo University Hospital.
• Implementation of imaging mass cytometry and automated whole-slideanalyses of colorectal and pancreatic cancer.
  Funded by Fondsstiftelsen at Oslo University Hospital.

Cooperation

Read also about our collaborative work on pancreatic cancer